Janus Henderson Group plc 13D and 13G filings for Seres Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 12:23 pm Sale |
2023-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
JANUS HENDERSON GROUP PLC JHG |
483 0.000% |
-11,247,809 (-100.00%) |
Filing |
| 2023-02-10 11:46 am Purchase |
2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
JANUS HENDERSON GROUP PLC JHG |
11,248,292 9.000% |
6,193,193 (+122.51%) |
Filing |
| 2022-02-11 3:11 pm Purchase |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
JANUS HENDERSON GROUP PLC JHG |
5,055,099 5.500% |
5,055,099 (New Position) |
Filing |